See also this year's filing and all EDGAR filings for this company.
PDF Report 0001533743_2018_Processa_Pharmaceuticals_Inc.pdf
Logs
| error | Negative Expenses, ignoring company. | pre-agg | {'expenses': -902801} |
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001533743, Processa Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,951,584 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 25,821 |
| 3 | remainder_Assets | 5,535 |
| 4 | LiabilitiesCurrent | 2,599,813 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 9,963 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 1,802,433 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -53,882 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,982,940 |
| 1 | Liabilities | 2,609,776 |
| 2 | Expenses | 1,802,433 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 373,164 |
| 5 | NetIncome | -1,856,315 |
| 6 | ComprehensiveNetIncome | -1,856,315 |
| 7 | BaseVar | 3,724,516 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.373 |
| 9 | EconomicCapitalRatio | 1.39 |
Edgar->Model Mapping
Feature Distribution
